Propranolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C16H21NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9Y8NXQ24VQ, chemically known as 2-propanol, 1- (isopropylamino)-3-(1-naphthyloxy)-, hydrochloride but generally known as propranolol, which bears US NIH Compound Identifier 4946. European Medicines Agency schedules Propranolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10119MIG. The term PROPRANOLOL is an International Non-Proprietary Name. World Health Organization schedules propranolol in its Anatomical Therapeutic Chemical (ATC) Classification. PROPRANOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule propranolol under HS 29221980 and SITC 51461. As of Q4 2014, PROPRANOLOL remains the US FDA Preferred Term for this commodity. Propranolol bears US NLM identifiers UMLS ID C0033497 and NCI Concept Code C62073. SMILES: O(CC(O)CNC(C)C)C1C2C(CCC1)CCCC2.